Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3

Journal of Nutritional Biochemistry

Volumn 26, Issue 11, 2015, Pages 1298-1307

  Bagul, Pankaj K ^a,b   Deepthi, Nancy ^a   Sultana, Razia ^a   Banerjee, Sanjay K ^a,b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

Author keywords

Acetylation; Diabetic cardiomyopathy; Histone; NFkB; Oxidative stress; Resveratrol; SIRT 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FRUCTOSE; GLUTATHIONE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; FRUCTOSAMINE; HISTONE; RELA PROTEIN, RAT; SIRT1 PROTEIN, RAT; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DIABETES MELLITUS; ECG ABNORMALITY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; QRS INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RAT; RR INTERVAL; SPRAGUE DAWLEY RAT; ACETYLATION; ANIMAL; CARDIOMEGALY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HEART; METABOLISM; PATHOPHYSIOLOGY;

ACETYLATION; ANIMALS; CARDIOMEGALY; DIABETES MELLITUS, EXPERIMENTAL; FRUCTOSAMINE; HEART; HISTONES; MALE; NADPH OXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; SIRTUIN 1; STILBENES; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

EID: 84946472612     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.06.006     Document Type: Article

References (39)

1. Amos A.F., McCarty D.J., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14(Suppl. 5):S1-S85.
2. Stone P.H., Muller J.E., Hartwell T., York B.J., Rutherford J.D., Parker C.B., et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 1989, 14:49-57.
3. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34.
4. Voulgari C., Papadogiannis D., Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag 2010, 6:883-903.
5. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
6. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 1994, 16:383-391.
7. Tan K.C., Chow W.S., Ai V.H., Metz C., Bucala R., Lam K.S. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002, 25:1055-1059.
8. Helenius M., Hanninen M., Lehtinen S.K., Salminen A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol 1996, 28:487-498.
9. Gordon J.W., Shaw J.A., Kirshenbaum L.A. Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circ Res 2011, 108:1122-1132.
10. Won J.H., Im H.T., Kim Y.H., Yun K.J., Park H.J., Choi J.W., et al. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation. Br J Pharmacol 2006, 148:216-225.
11. Huang B., Yang X.D., Lamb A., Chen L.F. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal 2010, 22:1282-1290.
12. Arnaudo A.M., Garcia B.A. Proteomic characterization of novel histone post-translational modifications. Epigenetics Chromatin 2013, 6:24.
13. Chen L.F., Greene W.C. Assessing acetylation of NF-kappaB. Methods 2005, 36:368-375.
14. Chen L.F., Mu Y., Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 2002, 21:6539-6548.
15. Buck S.W., Gallo C.M., Smith J.S. Diversity in the Sir2 family of protein deacetylases. J Leukoc Biol 2004, 75:939-950.
16. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
17. Rothgiesser K.M., Erener S., Waibel S., Luscher B., Hottiger M.O. SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 2010, 123:4251-4258.
18. Miatello R., Vazquez M., Renna N., Cruzado M., Zumino A.P., Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 2005, 18:864-870.
19. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
20. Lee M.J., Feliers D., Sataranatarajan K., Mariappan M.M., Li M., Barnes J.L., et al. Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 2010, 22:65-70.
21. Banerjee S.K., Dinda A.K., Manchanda S.C., Maulik S.K. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol 2002, 2:16.
22. Bagul P.K., Middela H., Matapally S., Padiya R., Bastia T., Madhusudana K., et al. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol Res 2012, 66:260-268.
23. Maity P., Bindu S., Dey S., Goyal M., Alam A., Pal C., et al. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J Biol Chem 2009, 284:3058-3068.
24. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
25. Abid M.R., Spokes K.C., Shih S.C., Aird W.C. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem 2007, 282:35373-35385.
26. Benzie I.F., Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999, 299:15-27.
27. Nakhaee A., Bokaeian M., Saravani M., Farhangi A., Akbarzadeh A. Attenuation of oxidative stress in streptozotocin-induced diabetic rats by Eucalyptus globulus. IJCB 2009, 24:419-425.
28. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994, 233:357-363.
29. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 2005, 24:55-99.
30. Vanithadevi B., ACV Effect of rosmarinic acid on insulin sensitivity, glyoxalase system and oxidative events in liver of fructose-fed mice. Int J Diabetes Metab 2008, 16:35-44.
31. A.J. In vitro antiglycation activity of arbutin. Naresuan Univ J 2005, 13:35-41.
32. Das M., Das S., Lekli I., Das D.K. Caveolin induces cardioprotection through epigenetic regulation. J Cell Mol Med 2012, 16:888-895.
33. Rosen P., Du X., Tschope D. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol?. Mol Cell Biochem 1998, 188:103-111.
34. Lorenzo O., Picatoste B., Ares-Carrasco S., Ramirez E., Egido J., Tunon J. Potential role of nuclear factor kappaB in diabetic cardiomyopathy. Mediat Inflamm 2011, 2011:652097.
35. Hwang Y.J., Lee E.W., Song J., Kim H.R., Jun Y.C., Hwang K.A. MafK positively regulates NF-kappaB activity by enhancing CBP-mediated p65 acetylation. Sci Rep 2013, 3:3242.
36. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
37. Manea A., Tanase L.I., Raicu M., Simionescu M. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun 2010, 396:901-907.
38. Bagul P.K., Banerjee S.K. Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins. Curr Pharm Des 2013, 19:5663-5677.
39. Morris B.J. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med 2013, 56:133-171.